---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-033049"
form_type: "8-K"
ticker: "INBP"
cik: "0001016504"
company_name: "INTEGRATED BIOPHARMA INC"
filed_at: "2023-11-27T23:59:59+00:00"
generated_at: "2026-06-07T21:17:13.034097+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Integrated BioPharma holds 2023 annual meeting; elects Class II directors, approves advisory pay vote, ratifies auditor

## Summary
- Christina Kay, Robert Canarick, and William H. Milmoe elected as Class II directors to serve until 2026.
- Non-binding advisory vote on executive compensation approved: 19,964,583 for, 2,510,524 against, 1,715 abstain.
- Ratification of Marcum LLP as independent auditor for FY ending June 30, 2024 passed: 23,762,534 for, 7,281 against.
- Vote results: Kay 20,393,822 for; Canarick 22,301,725 for; Milmoe 22,285,400 for.

## SEC filing metadata
- accession: 0001437749-23-033049
- form_type: 8-K
- ticker: INBP
- cik: 0001016504
- company_name: INTEGRATED BIOPHARMA INC
- filed_at: 2023-11-27T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1016504/000143774923033049/0001437749-23-033049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1016504/000143774923033049/inbp20231127_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-033049
- JSON: https://secwatch.observer/filing/0001437749-23-033049.json
- Plain text: https://secwatch.observer/filing/0001437749-23-033049.txt

## Key facts
- Shareholder Votes
  INTEGRATED BIOPHARMA INC shareholders approved Election of Class II directors for a three-year term at the 2023-11-27 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-11-27
  source text: Christina Kay 20,393,822 2,083,000 1,292,993 Robert Canarick 22,301,725 175,097 1,292,993 William H Milmoe 22,285,400 191,422 1,292,993
  evidence_url: https://www.sec.gov/Archives/edgar/data/1016504/000143774923033049/0001437749-23-033049-index.htm
- Shareholder Votes
  INTEGRATED BIOPHARMA INC shareholders approved Ratify the appointment of Marcum LLP as the Company’s independent auditors for fiscal year ending June 30, 2024 at the 2023-11-27 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-11-27
  source text: For Against Abstain 23,762,534 7,281 -
  evidence_url: https://www.sec.gov/Archives/edgar/data/1016504/000143774923033049/0001437749-23-033049-index.htm
- Shareholder Votes
  INTEGRATED BIOPHARMA INC shareholders approved Non-binding, Advisory Vote on Executive Compensation at the 2023-11-27 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-11-27
  source text: For Against Abstain Broker Non-Votes 19,964,583 2,510,524 1,715 1,292,993
  evidence_url: https://www.sec.gov/Archives/edgar/data/1016504/000143774923033049/0001437749-23-033049-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.